Utama › Leukemia Limfoblastik Akut › New York

Kajian klinikal Leukemia Limfoblastik Akut di New York

32 kajian untuk Leukemia Limfoblastik Akut sedang mencari peserta di lokasi di New York.

Bandar di New York

Teks kajian rasmi (Bahasa Inggeris)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Queens Hospital Center, Jamaica
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Stony Brook University Medical Center, Stony Brook

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan

Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Memorial Sloan Kettering Cancer Center, New York

Mengambil pesertaFasa 1

Umur 12 hingga 78 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT03802695

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

Memorial Sloan Kettering Cancer Center -- Pediatrics, New York

Mengambil pesertaFasa 2

6 Months · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06514794

Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children

Columbia University Medical Center, New York

Mengambil pesertaKajian pemerhatian

4 Weeks – 18 Years · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06529575

Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Montefiore Einstein Comprehensive Cancer Center, The Bronx

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT06308588

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Montefiore Medical Center, New York

Mengambil pesertaFasa 1/2

30 Days · Semua jantina · Dikemas kini 16 Sep 2026 · NCT04065399

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

The Mount Sinai Hospital, New York

Mengambil pesertaFasa 1

Umur 0 hingga 18 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT06173518

Cord Blood Transplant in Adults With Blood Cancers

Memorial Sloan Kettering Cancer Center, New York

Mengambil pesertaFasa 2

Umur 21 hingga 65 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT05884333

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

Memorial Sloan Kettering Cancer Center, New York

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 1 Sep 2026 · NCT07586618

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Albany Medical Center, Albany
Maimonides Medical Center, Brooklyn
NYU Langone Hospital - Long Island, Mineola
dan 7 lagi

Mengambil pesertaFasa 1/2

Sehingga umur 22 · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT04726241

A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia

Memorial Sloan Kettering Cancer Commack - Suffolk (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
dan 1 lagi

Mengambil pesertaFasa 2

Umur 40 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT07400029

A Study of CTD402 in T-ALL/LBL Patients

Memorial Sloan Kettering Cancer Center, New York
Montefiore Einstein Comprehensive Cancer Center, The Bronx

Mengambil pesertaFasa 1/2

Umur 1 ke atas · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT07070219

MedSupport Intervention to Identify and Address Barriers to Pediatric Medication Adherence

Roswell Park Cancer Institute, Buffalo

Mengambil pesertaSukarelawan sihat dialu-alukan

Semua umur · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT06323044

Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

Research Site, New York

Mengambil pesertaFasa 1/2

Umur 16 ke atas · Semua jantina · Dikemas kini 20 Jul 2026 · NCT07155226

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Roswell Park Cancer Institute, Buffalo
North Shore University Hospital, Lake Sucess
Cohen Children's Medical Center of New York, New Hyde
dan 9 lagi

Mengambil pesertaKajian pemerhatian

Semua umur · Semua jantina · Dikemas kini 6 Jul 2026 · NCT01351545

A Study of Revumenib and Mezigdomide in People With Leukemia

Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
dan 1 lagi

Mengambil pesertaFasa 1/2

Umur 12 ke atas · Semua jantina · Dikemas kini 22 Jun 2026 · NCT07356154

TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II

Memorial Sloan Kettering Cancer Center, New York

Mengambil pesertaFasa 1/2

Sehingga umur 1 · Semua jantina · Dikemas kini 3 Jun 2026 · NCT05848687

European Prospective Investigation Into Childhood Cancer

Columbia University Irving Medical Center, New York

Mengambil pesertaKajian pemerhatian

Umur 3 hingga 21 · Semua jantina · Dikemas kini 2 Jun 2026 · NCT05375617

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
University of Rochester, Rochester
Stony Brook University Medical Center, Stony Brook
dan 1 lagi

Mengambil pesertaKajian pemerhatian

Semua umur · Semua jantina · Dikemas kini 18 Mei 2026 · NCT01790152

Cord Blood Transplantation in Children and Young Adults With Blood Cancer

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

Mengambil pesertaFasa 2

Sehingga umur 26 · Semua jantina · Dikemas kini 14 Mei 2026 · NCT07566377

A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)

Ascentage Investigative Site #1160, Stony Brook
Ascentage Investigative Site #1151, The Bronx

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 30 Apr 2026 · NCT06051409

Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3

Roswell Park Comprehensive Cancer Center, Buffalo

Mengambil peserta

Umur 3 hingga 9 · Semua jantina · Dikemas kini 23 Apr 2026 · NCT06074666

Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)

The Mt. Hope Family Center, Rochester

Mengambil peserta

Umur 8 hingga 17 · Semua jantina · Dikemas kini 8 Apr 2026 · NCT06956781

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Roswell Park Comprehensive Cancer Center, Buffalo

Mengambil pesertaFasa 1/2

Umur 12 ke atas · Semua jantina · Dikemas kini 24 Mac 2026 · NCT04988555

A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

University of Rochester Medical Center, Wilmot Cancer Center, Rochester

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 18 Mac 2026 · NCT06207123

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Memorial Sloan Kettering, New York

Mengambil pesertaFasa 2

Umur 18 hingga 66 · Semua jantina · Dikemas kini 17 Mac 2026 · NCT06859424

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Memorial Sloan Kettering Cancer Center, New York

Mengambil pesertaFasa 2

Umur 18 hingga 54 · Semua jantina · Dikemas kini 17 Mac 2026 · NCT06918431

A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)

Memorial Sloan Kettering Cancer Suffolk-Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
dan 1 lagi

Mengambil pesertaFasa 1

Umur 17 ke atas · Semua jantina · Dikemas kini 10 Feb 2026 · NCT06287528

Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL

Memorial Sloan Kettering Cancer Center, New York

Mengambil pesertaFasa 1

Umur 12 ke atas · Semua jantina · Dikemas kini 8 Jan 2026 · NCT04872478

A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors

Columbia University Medical Center, New York

Mengambil peserta

Umur 5 hingga 21 · Semua jantina · Dikemas kini 7 Okt 2025 · NCT05963971

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

Memorial Sloan Kettering Cancer Center, New York

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 15 Apr 2025 · NCT06462365

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Children's Hospital New York-Presbyterian, New York
Memorial Sloan Kettering Cancer Center, New York

Mengambil pesertaFasa 1

Umur 1 hingga 21 · Semua jantina · Dikemas kini 6 Dis 2024 · NCT05476770

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.